Myelodysplastic syndrome and acute myeloid leukemia are heterogeneous myeloid
neoplasms which arise from the accumulation of mutations in a myeloid stem cell or …

Abstract Purpose of Review We review how understanding the fitness and comorbidity
burden of patients, and molecular landscape of underlying acute myeloid leukemia (AML) …

We report the results from a multicentre retrospective study of 220 adult patients who
underwent allogeneic hematopoietic stem cell transplantation (alloHSCT) for therapy-related …

Introduction Neutropenic enterocolitis (NEC) is a life-threatening complication reported in
patients with acute myeloid leukemia (AML) following chemotherapy (CHT). Intensive …

Secondary acute myeloid leukemia includes acute myeloid leukemia that arises either from
a previous myeloid hematologic disease such as myelodysplastic syndrome, chronic …

Simple Summary Assessment of measurable residual disease (MRD) identifies small
numbers of acute myeloid leukemia (AML) cells that may remain after initiating treatment …

Unsupervised clustering is an essential step in identifying cell types from single‐cell RNA
sequencing (scRNA‐seq) data. However, a common issue with unsupervised clustering …

Several scoring systems have been developed to assess suitability of individual patients for
intensive acute myeloid leukemia (AML) therapy. We sought to compare the performance of …

Acute myeloid leukemia (AML) is the most common acute leukemia in adults in the United
States and has seen the approval of several novel agents over the past decade. Similar to …

Background: Acute myeloid leukemia (AML) is a disease of the hematopoietic system that
remains a therapeutic challenge despite advances in our understanding of the underlying …